Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • Advertisement

    Opinion

    Mark Draper

    This routine health test is an investment opportunity

    The share prices of pathology companies are below pre-pandemic levels and the world will need more blood tests.

    Mark DraperContributor

    Subscribe to gift this article

    Gift 5 articles to anyone you choose each month when you subscribe.

    Subscribe now

    Already a subscriber?

    Some of the best investment ideas come from observing daily life. Smartphones have around 90 per cent penetration rate in Australia, according to statista.com, which has resulted in many profitable investments including Apple, Facebook, REA Group and Life360 just to name a few.

    Doctor’s visits are a normal part of life for most people, and pathology tests are a natural consequence of visiting a doctor. This sector is investible too.

    Subscribe to gift this article

    Gift 5 articles to anyone you choose each month when you subscribe.

    Subscribe now

    Already a subscriber?

    Read More

    Latest In Personal finance

    Fetching latest articles

    Most Viewed In Wealth